X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel.
General anaesthetics have enjoyed long and widespread use but their molecular mechanism of action remains poorly understood. There is good evidence that their principal targets are pentameric ligand-gated ion channels (pLGICs) such as inhibitory GABA(A) (γ-aminobutyric acid) receptors and excitatory nicotinic acetylcholine receptors, which are respectively potentiated and inhibited by general anaesthetics. The bacterial homologue from Gloeobacter violaceus (GLIC), whose X-ray structure was recently solved, is also sensitive to clinical concentrations of general anaesthetics. Here we describe the crystal structures of the complexes propofol/GLIC and desflurane/GLIC. These reveal a common general-anaesthetic binding site, which pre-exists in the apo-structure in the upper part of the transmembrane domain of each protomer. Both molecules establish van der Waals interactions with the protein; propofol binds at the entrance of the cavity whereas the smaller, more flexible, desflurane binds deeper inside. Mutations of some amino acids lining the binding site profoundly alter the ionic response of GLIC to protons, and affect its general-anaesthetic pharmacology. Molecular dynamics simulations, performed on the wild type (WT) and two GLIC mutants, highlight differences in mobility of propofol in its binding site and help to explain these effects. These data provide a novel structural framework for the design of general anaesthetics and of allosteric modulators of brain pLGICs.
Institut Pasteur, Groupe Récepteurs-Canaux, F-75015 Paris, France.
Hugues
H
Nury
Catherine
C
Van Renterghem
Yun
Y
Weng
Alphonso
A
Tran
Marc
M
Baaden
Virginie
V
Dufresne
Jean-Pierre
JP
Changeux
James M
JM
Sonner
Marc
M
Delarue
Pierre-Jean
PJ
Corringer
D018681:Anesthetics, General / Q000737:chemistry* / Q000378:metabolism*; D001665:Binding Sites / Q000235:genetics; D018360:Crystallography, X-Ray; D000458:Cyanobacteria / Q000737:chemistry*; D000077335:Desflurane; D055724:Electrophysiological Phenomena; D007530:Isoflurane / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D058446:Ligand-Gated Ion Channels / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D008024:Ligands; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D050505:Mutant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D015742:Propofol / Q000737:chemistry* / Q000378:metabolism; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011522:Protons
D018681:Anesthetics, General; D058446:Ligand-Gated Ion Channels; D008024:Ligands; D050505:Mutant Proteins; D011522:Protons; D000077335:Desflurane; D007530:Isoflurane; D015742:Propofol
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
J Mol Graph Model. 2006 Dec;25(4):481-6
16644253
J Biol Chem. 2008 Aug 1;283(31):21478-86
18511419
Nature. 1991 Oct 31;353(6347):846-9
1719423
Anesthesiology. 1997 Apr;86(4):866-74
9105231
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Nature. 2006 Nov 23;444(7118):486-9
17108970
Nature. 2009 Jan 1;457(7225):111-4
18987633
J Morphol. 1972 Feb;136(2):153-79
4109871
Int Rev Neurobiol. 2005;65:53-87
16140053
J Biol Chem. 2004 Apr 23;279(17):17640-9
14761946
J Biol Chem. 2009 Dec 4;284(49):33841-9
19815550
Mol Pharmacol. 1998 Feb;53(2):283-94
9463487
Nat Rev Drug Discov. 2009 Sep;8(9):733-50
19721446
Anesth Analg. 2010 Jan 1;110(1):59-63
19933531
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
15299374
J Mol Biol. 1966 Nov 14;21(2):265-74
5972463
Nat Struct Mol Biol. 2010 Jan;17(1):90-8
20023641
Nature. 1984 Aug 16-22;310(5978):599-601
6462249
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
15299926
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
17452350
Nature. 2007 Jan 4;445(7123):116-9
17167423
J Physiol. 1982 Jul;328:143-70
7131311
Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
15272157
J Biol Chem. 2000 Dec 8;275(49):38731-8
10940303
J Embryol Exp Morphol. 1959 Jun;7:210-22
13797228
J Comput Chem. 2005 Dec;26(16):1781-802
16222654
J Biol Chem. 2009 Sep 4;284(36):24176-84
19605349
J Phys Chem B. 1998 Apr 30;102(18):3586-616
24889800
J Neurosci. 2009 Feb 25;29(8):2440-52
19244519
Nature. 2008 Mar 20;452(7185):375-9
18322461
Nat Rev Neurosci. 2008 May;9(5):370-86
18425091
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6275-80
20308576
Nature. 2003 Jun 26;423(6943):949-55
12827192
J Biol Chem. 2010 Mar 19;285(12):8615-20
20083606
Biochem Pharmacol. 2007 Oct 15;74(8):1155-63
17707779
Nature. 2009 Jan 1;457(7225):115-8
18987630
J Neurosci. 2009 Mar 11;29(10):3083-92
19279245
Nature. 1997 Sep 25;389(6649):385-9
9311780
J Mol Graph Model. 2004 Sep;23(1):39-49
15331052
J Neurosci. 2006 Nov 8;26(45):11599-605
17093081
FASEB J. 2009 Aug;23(8):2735-40
19332643